Clinical Trial Packaging Market (By Packaging Type: Syringes, Blisters, Tubes, Bottles, Bags & Pouches, Others; By Material, By End Use) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook and Forecast 2022 - 2030

The global clinical trial packaging market size was valued at US$ 1.8 billion in 2021 and is expected to reach around US$ 3.7 billion by 2030, growing at a CAGR of 7.5% during the forecast period 2022 to 2030. The market is estimated to be driven by rising clinical trial activities coupled with rapid adoption of contract manufacturing in the pharma sector.

The clinical trial packaging solutions are used in various end-use industries for packaging, storing, protecting, and transporting clinical trial products. Clinical trial packaging solutions consist of syringes, vials & ampoules, blisters, tubes, bottles, etc. are predominantly used in research laboratories, clinical research organizations, and drug manufacturing facilities. The VRR team segmented the analysis of clinical trial packaging market based on packaging type, material, and end use. As per VRR analysis, research laboratories in the global clinical trial packaging market is expected to account for a lion’s share of the market, and expected to lead the overall clinical trial packaging market during the forecast period.

Innovative Concepts, Discovery of New Drugs to Fuel Market Growth

Research and development activities within the pharmaceutical sector have shifted gears in recent years, due to the increasing demand for new drugs and therapies– a factor that is expected to bolster the global clinical trial packaging market. The demand for glass bottles is on the rise owing to mounting concerns pertaining to the use of plastic. The consistent surge in the number of chronic diseases cases, including cancer, HIV, and epilepsy is expected to have a strong impact on the development of the global clinical trial packaging market during the assessment period. The rise in the number of research & development, along with the increasing support from governments for the development of new drugs, is anticipated to accelerate the growth of the global clinical trial packaging market during the assessment period.

Some of the factors that could hinder the growth of the clinical trial packaging market include lack of modern infrastructure in underdeveloped and developing regions and scarcity of trained personnel. Market players involved in the current clinical trial packaging market are increasingly focusing on developing their packaging solutions that can withstand filling, handling, transportation, etc. The advent of innovative pharmaceutical packaging concepts, including blow fill seal vials, two-in-one prefilled vial deigns, prefilled syringes, snap off ampoules, and child-resistant packs is projected to provide an impetus to growth of the global clinical trial packaging market during the assessment period.

Companies to Develop New Packaging Solutions to Hinder COVID-19 Spread

The advent of the COVID-19 pandemic is expected to have a strong influence on the clinical trial packaging market in 2020 and beyond. In the current scenario, market players are focusing on the development of new materials to meet packaging requirements during the COVID-19 crisis. The increasing demand for safe, sustainable, and hygienic packaging alternatives for healthcare products and eCommerce transportation is expected to augment the growth of the global clinical trial packaging market during the forecast period. The decline in the consumer demand for plastic packaging is anticipated to drive innovations across the clinical trial packaging market.

Due to the outbreak of the COVID-19 pandemic, the demand for medical device kits and certain medicines has witnessed exponential growth. This factor is expected to fuel the expansion of the global clinical trial packaging market. Furthermore, the contract packaging trend has gained considerable momentum during the COVID-19 crisis. Thus, the demand for pressure sensitive labels, folding cartons, and convenient vial filling has increased. Market players are also estimated to expand their manufacturing capacities during the ongoing pandemic to cater to the surge in the demand.

Current Trend of Contract Manufacturing in Pharmaceuticals Industry Drives Market

  • Rapidly rising clinical trials and research & development activities among leading pharmaceutical companies across the globe have created the massive demand for contract manufacturing in the global pharmaceutical industry. These contract manufacturing organizations offer services related to active pharmaceutical ingredient (API) production, drug product development, and packaging.
  • Furthermore, leading pharmaceutical companies are opting for contract manufacturing organizations for clinical trials, as they lower several costs such as operational, transportation, and logistics
  • This current trend of outsourcing in global pharmaceutical industry for clinical trials is anticipated to drive the clinical trial packaging market during the forecast period

Manufacturers Target High Potential Asian Countries

  • High potential Asian countries such as India and China are leading manufacturers and exporters of pharmaceutical drugs across the globe. Growing private sector and regional government investments in pharmaceutical R&D in Asian countries has opened new doors of opportunities for clinical trial packaging manufacturers. Pharmaceutical industry in the Asia Pacific region has witnessed outstanding market growth in recent years and likely to experience significant market growth during the upcoming years. Manufacturers operating in the global clinical trial packaging market can target these lucrative countries on the back of rising pharmaceutical clinical trials activities in these countries.
  • Furthermore, low production and packaging cost in Asia Pacific region led clinical trial packaging manufacturers to expand their business boundaries to Asian countries. Thus, packaging manufacturers can focus on Asian countries to reinforce their market position and financial profitability as well.

Frequent Need of Booklet Labels in Clinical Trials Augment Sales

  • Global clinical trial packaging market is characterized by R&D and new formulations of several drugs. Packaging solutions such as multiply booklet labels are frequently used in packaging of clinical research trials. These booklet labels provide multi-functionality features for communicating variable data through labelling. Booklet labels allow packaging manufacturers to summarize enormous paperwork in compressed spaces.
  • Furthermore, booklet labels used in clinical trial packaging support labelling requirements that cover the integration of several languages, regulation compliance of multiple countries, and accommodation in clear structure and legible content. Rising demand for such booklet labels in clinical trials is likely to accelerate market growth during the foreseeable future.

Key Findings

  • Based on material, the plastic segment is projected to lead the overall clinical trial packaging market with capturing more than half of the market share in 2021. The same segment is projected to offer total incremental opportunity of US$ 470 Mn with expansion of 1.7x times by its value during the next seven years.
  • In terms of end use, research laboratories segment is expected to be the most lucrative segment of the clinical trial packaging market. The same segment is generating consistent demand for clinical trial packaging solutions and anticipated to hold more than 60% portion of total market share by the end of 2030. 
  • By Region, in terms of market share and revenue generation, North America region is anticipated to outpace the global clinical trial packaging market. Rapid penetration coupled with increase in R&D activities in the pharmaceutical industry in North America is fueling market growth during the forecast period.

COVID-19 Impact: Rise in Clinical Trials Supplements Sales

  • Prominent pharmaceutical companies across the globe are consistently carrying several clinical trials to develop and launch new vaccines against the COVID-19 virus. Global spread of novel COVID-19 has driven leading pharmaceutical companies to conduct high number of clinical trials to battle against the pandemic. This, in turn, has created massive demand for pharmaceutical packaging solutions, including clinical trial packaging.
  • In addition, this rising demand for clinical trials packaging solutions such as vials & ampoules, syringes, and bottles, among others, is not only in mature markets of North America and Europe, but also in Asian countries. Overall, COVID-19 pandemic has somehow fueled the demand for clinical trials packaging solutions.

Key Players

Some of the key players operating in the global clinical trial packaging market are Bilcare Limited, Westrock Company, Fisher Clinical Services, Almac Group Limited, PAREXEL International Corporation, The Coghlan Group, Piramal Enterprises Ltd, WuXi AppTec, PCI Pharma Services, and Pharmaterials Ltd, among others.

Market Segmentation

By Packaging Type

  • Syringes
  • Vials & Ampoules
  • Blisters
    • Cold Forming
    • Thermoforming
  • Tubes
  • Bottles
  • Bags & Pouches
  • Sachets
  • Kits or Packs
  • Others

By Material

  • Plastic
    • PVC
    • PE
      • HDPE
      • LDPE
    • PP
    • Others
  • Glass
  • Metal
  • Paper
  • Corrugated Fiber

By End Use

  • Research Laboratories
  • Clinical Research Organizations
  • Drug Manufacturing Facilities

Clinical Trial Packaging Market by Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Scope of the Report

A new study on the global clinical trial packaging market, providing forecast for the period of 2021-2028. In the study, growth opportunity for the clinical trial packaging market is witnessed. The report provides valuable insights, which enable readers to make winning business decisions for future growth of their businesses. The report highlights significant factors that are constantly determining the growth of the clinical trial packaging market, untapped opportunities for manufacturers, trends & developments, and other insights across various key segments. Macroeconomic factors that are directly or indirectly affecting market growth are also incorporated in the report.

Key Questions

  • What will be market size for clinical trial packaging by the end of 2028?
  • What will be the impact of COVID-19 on clinical trial packaging market?
  • Which is the most preferred material for manufacturing clinical trial packaging solutions in the global market?
  • Which region will remain most lucrative for market growth?
  • Which end use holds maximum market share in the global clinical trial packaging market?
  • Who are major key players in the clinical trial packaging market?

Key indicators associated with the clinical trial packaging market have been calculated thoroughly in the report. The study enumerates vital market dynamics such as key drivers, challenges, and trends, along with opportunities in the global clinical trial packaging market. A comprehensive study on the value chain, which includes component suppliers, manufacturers, distributors, and end users, has been incorporated in the global market report. Other key aspects laid down in the market include pricing strategy of leading market players and comparative analysis of clinical trial packaging. Furthermore, forecast factors and forecast scenarios of the clinical trial packaging market have been covered in the report to understand future prospects of the market.

A comprehensive evaluation and forecast on the clinical trial packaging market are provided on the packaging type, material, end use, and region.

Y-o-Y growth comparison, volume and revenue comparison, and market share comparison of various market segments are provided in the report. The clinical trial packaging market is analyzed at both regional and country levels.

The report delivers an exhaustive assessment on the structure of the clinical trial packaging market, in tandem with a dashboard view of all leading company profiles in the report. Every company’s share analysis on market players have also been presented in the report, apart from the footprint matrix of profiled market players. The report depicts the presence of clinical trial packaging manufacturers by leveraging an intensity map. It also highlights key end uses for clinical trial packaging.

Research Methodology

A realistic methodology, along with a holistic approach makes the base for sharp insights, which are provided in the clinical trial packaging market for the study evaluation period. The report comprises of detailed information on growth prospects, along with riveting insights into the forecast assessment of the market.

Extensive primary and secondary researches have been employed to garner keen insights into the forecast study of the clinical trial packaging market. The report has further undergone a cross-validation by in-house professionals to make the clinical trial packaging market report one-of-its-kind, with the highest credibility.

1. Executive Summary

    1.1. Market Overview

    1.2. Market Analysis

2. Market Viewpoint

    2.1. Market Definition

    2.2. Market Taxonomy

3. Clinical Trial Packaging Market Overview

    3.1. Introduction

    3.2. Macro-economic Factors – Correlation Analysis

    3.3. Forecast Factors – Relevance & Impact

    3.4. Clinical Trial Packaging Market Value Chain Analysis

        3.4.1. Exhaustive List of Active Participants

            3.4.1.1. Manufacturers

            3.4.1.2. Distributors/Retailers

            3.4.1.3. End Users

        3.4.2. Profitability Margins

4. Impact of COVID-19

    4.1. Current Statistics and Probable Future Impact 

    4.2. Current Economic Projection – GDP/GVA and Probable Impact 

    4.3. Comparison of SAARs and Market Recovery, for Key Countries 

    4.4. Comparison to 2008 Financial Crisis and Market Recovery, for Key Countries 

    4.5. Impact of COVID-19 on Target Market

5. Clinical Trial Packaging Market Analysis 

    5.1. Pricing Analysis

        5.1.1. Pricing Assumption

        5.1.2. Price Projections By Region

    5.2. Market Size (US$ Mn) and Forecast

        5.2.1. Market Size and Y-o-Y Growth

        5.2.2. Absolute $ Opportunity

6. Clinical Trial Packaging Market Dynamics

    6.1. Drivers

    6.2. Restraints

    6.3. Opportunity Analysis

    6.4. Trends

7. Global Clinical Trial Packaging Market Analysis and Forecast, By Packaging Type

    7.1. Introduction

        7.1.1. Market share and Basis Points (BPS) Analysis, By Packaging Type

        7.1.2. Y-o-Y Growth Projections, By Packaging Type

    7.2. Historical Market Value(US$ Mn) and Volume (Units), 2017-2020, By Packaging Type

        7.2.1. Syringes

        7.2.2. Vials & Ampoules

        7.2.3. Blisters

            7.2.3.1. Cold Forming

            7.2.3.2. Thermoforming

        7.2.4. Tubes

        7.2.5. Bottles

        7.2.6. Bags & Pouches

        7.2.7. Sachets

        7.2.8. Kits or Packs

        7.2.9. Others

    7.3. Market Size (US$ Mn) and Volume (Units) Forecast Analysis 2021-2028, By Packaging Type

        7.3.1. Syringes

        7.3.2. Vials & Ampoules

        7.3.3. Blisters

            7.3.3.1. Cold Forming

            7.3.3.2. Thermoforming

        7.3.4. Tubes

        7.3.5. Bottles

        7.3.6. Bags & Pouches

        7.3.7. Sachets

        7.3.8. Kits or Packs

        7.3.9. Others

    7.4. Market Attractiveness Analysis, By Packaging Type

8. Global Clinical Trial Packaging Market Analysis and Forecast, By Material

    8.1. Introduction

        8.1.1. Market share and Basis Points (BPS) Analysis, By Material

        8.1.2. Y-o-Y Growth Projections, By Material

    8.2. Historical Market Value(US$ Mn) and Volume (Units), 2017-2020, By Material

        8.2.1. Plastic

            8.2.1.1. PVC

            8.2.1.2. PE

                8.2.1.2.1. HDPE

                8.2.1.2.2. LDPE

            8.2.1.3. PP

            8.2.1.4. Others

        8.2.2. Glass

        8.2.3. Metal 

        8.2.4. Paper

        8.2.5. Corrugated Fiber

    8.3. Market Size (US$ Mn) and Volume (Units) Forecast Analysis 2021-2028, By Material

        8.3.1. Plastic

            8.3.1.1. PVC

            8.3.1.2. PE

                8.3.1.2.1. HDPE

                8.3.1.2.2. LDPE

            8.3.1.3. PP

            8.3.1.4. Others

        8.3.2. Glass

        8.3.3. Metal 

        8.3.4. Paper

        8.3.5. Corrugated Fiber

    8.4. Market Attractiveness Analysis, By Material

9. Global Clinical Trial Packaging Market Analysis and Forecast, By End Use 

    9.1. Introduction

        9.1.1. Market share and Basis Points (BPS) Analysis, By End Use

        9.1.2. Y-o-Y Growth Projections, By End Use

    9.2. Historical Market Value(US$ Mn) and Volume (Units), 2017-2020, By End Use

        9.2.1. Research Laboratories

        9.2.2. Clinical Research Organization

        9.2.3. Drug Manufacturing Facilities

    9.3. Market Size (US$ Mn) and Volume (Units) Forecast Analysis 2021-2028, By End Use

        9.3.1. Research Laboratories

        9.3.2. Clinical Research Organization

        9.3.3. Drug Manufacturing Facilities

    9.4. Market Attractiveness Analysis, By End Use

    9.5. Prominent Trends

10. Global Clinical Trial Packaging Market Analysis and Forecast, By Region

    10.1. Introduction

        10.1.1. Market share and Basis Points (BPS) Analysis By Region

        10.1.2. Y-o-Y Growth Projections By Region

    10.2. Historical Market Value(US$ Mn) and Volume (Units), 2017-2020, By Region

        10.2.1. North America

        10.2.2. Latin America

        10.2.3. Europe

        10.2.4. Asia Pacific 

        10.2.5. Middle East & Africa (MEA)

    10.3. Market Size (US$ Mn) and Volume (Units) Forecast Analysis 2021-2028 By Region

        10.3.1. North America

        10.3.2. Latin America

        10.3.3. Europe

        10.3.4. Asia Pacific 

        10.3.5. Middle East & Africa (MEA)

    10.4. Market Attractiveness Analysis By Region

    10.5. Prominent Trends

11. North America Clinical Trial Packaging Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Market share and Basis Points (BPS) Analysis, By Country

        11.1.2. Y-o-Y Growth Projections, By Country

    11.2. Historical Market Value(US$ Mn) and Volume (Units), 2017-2020, By Country

    11.3. Market Size (US$ Mn) and Volume (Units) Forecast Analysis 2021-2028, By Country

        11.3.1. U.S.

        11.3.2. Canada

    11.4. Historical Market Value(US$ Mn) and Volume (Units), 2017-2020, By Packaging Type

    11.5. Market Size (US$ Mn) and Volume (Units) Forecast Analysis 2021-2028, By Packaging Type

        11.5.1. Syringes

        11.5.2. Vials & Ampoules

        11.5.3. Blisters

            11.5.3.1. Cold Forming

            11.5.3.2. Thermoforming

        11.5.4. Tubes

        11.5.5. Bottles

        11.5.6. Bags & Pouches

        11.5.7. Sachets

        11.5.8. Kits or Packs

        11.5.9. Others

    11.6. Historical Market Value(US$ Mn) and Volume (Units), 2017-2020, By Material

    11.7. Market Size (US$ Mn) and Volume (Units) Forecast Analysis 2021-2028, By Material

        11.7.1. Plastic

            11.7.1.1. PVC

            11.7.1.2. PE

                11.7.1.2.1. HDPE

                11.7.1.2.2. LDPE

            11.7.1.3. PP

            11.7.1.4. Others

        11.7.2. Glass

        11.7.3. Metal 

        11.7.4. Paper

        11.7.5. Corrugated Fiber

    11.8. Historical Market Value(US$ Mn) and Volume (Units), 2017-2020, By End Use

    11.9. Market Size (US$ Mn) and Volume (Units) Forecast Analysis 2021-2028, By End Use

        11.9.1. Research Laboratories

        11.9.2. Clinical Research Organization

        11.9.3. Drug Manufacturing Facilities

    11.10. Market Attractiveness Analysis

        11.10.1. By Country

        11.10.2. By Packaging Type

        11.10.3. By Material

        11.10.4. By End Use

    11.11. Prominent Trends

    11.12. Drivers and Restraints: Impact Analysis

12. Latin America Clinical Trial Packaging Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Market share and Basis Points (BPS) Analysis, By Country

        12.1.2. Y-o-Y Growth Projections, By Country

    12.2. Historical Market Value(US$ Mn) and Volume (Units), 2017-2020, By Country

    12.3. Market Size (US$ Mn) and Volume (Units) Forecast Analysis 2021-2028 By Country

        12.3.1. Brazil

        12.3.2. Mexico

        12.3.3. Argentina

        12.3.4. Rest of Latin America

    12.4. Historical Market Value(US$ Mn) and Volume (Units), 2017-2020, By Packaging Type

    12.5. Market Size (US$ Mn) and Volume (Units) Forecast Analysis 2021-2028, By Packaging Type

        12.5.1. Syringes

        12.5.2. Vials & Ampoules

        12.5.3. Blisters

            12.5.3.1. Cold Forming

            12.5.3.2. Thermoforming

        12.5.4. Tubes

        12.5.5. Bottles

        12.5.6. Bags & Pouches

        12.5.7. Sachets

        12.5.8. Kits or Packs

        12.5.9. Others

    12.6. Historical Market Value(US$ Mn) and Volume (Units), 2017-2020, By Material

    12.7. Market Size (US$ Mn) and Volume (Units) Forecast Analysis 2021-2028, By Material

        12.7.1. Plastic

            12.7.1.1. PVC

            12.7.1.2. PE

                12.7.1.2.1. HDPE

                12.7.1.2.2. LDPE

            12.7.1.3. PP

            12.7.1.4. Others

        12.7.2. Glass

        12.7.3. Metal 

        12.7.4. Paper

        12.7.5. Corrugated Fiber

    12.8. Historical Market Value(US$ Mn) and Volume (Units), 2017-2020, By End Use

    12.9. Market Size (US$ Mn) and Volume (Units) Forecast Analysis 2021-2028, By End Use

        12.9.1. Research Laboratories

        12.9.2. Clinical Research Organization

        12.9.3. Drug Manufacturing Facilities

    12.10. Market Attractiveness Analysis

        12.10.1. By Country

        12.10.2. By Packaging Type

        12.10.3. By Material

        12.10.4. By End Use

    12.11. Prominent Trends

    12.12. Drivers and Restraints: Impact Analysis

13. Europe Clinical Trial Packaging Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Market share and Basis Points (BPS) Analysis, By Country

        13.1.2. Y-o-Y Growth Projections, By Country

    13.2. Historical Market Value(US$ Mn) and Volume (Units), 2017-2020, By Country

    13.3. Market Size (US$ Mn) and Volume (Units) Forecast Analysis 2021-2028 By Country

        13.3.1. Germany

        13.3.2. Spain

        13.3.3. Italy

        13.3.4. France

        13.3.5. U.K.

        13.3.6. BENELUX

        13.3.7. Nordic

        13.3.8. Russia

        13.3.9. Poland

        13.3.10. Rest of Europe

    13.4. Historical Market Value(US$ Mn) and Volume (Units), 2017-2020, By Packaging Type

    13.5. Market Size (US$ Mn) and Volume (Units) Forecast Analysis 2021-2028, By Packaging Type

        13.5.1. Syringes

        13.5.2. Vials & Ampoules

        13.5.3. Blisters

            13.5.3.1. Cold Forming

            13.5.3.2. Thermoforming

        13.5.4. Tubes

        13.5.5. Bottles

        13.5.6. Bags & Pouches

        13.5.7. Sachets

        13.5.8. Kits or Packs

        13.5.9. Others

    13.6. Historical Market Value(US$ Mn) and Volume (Units), 2017-2020, By Material

    13.7. Market Size (US$ Mn) and Volume (Units) Forecast Analysis 2021-2028, By Material

        13.7.1. Plastic

            13.7.1.1. PVC

            13.7.1.2. PE

                13.7.1.2.1. HDPE

                13.7.1.2.2. LDPE

            13.7.1.3. PP

            13.7.1.4. Others

        13.7.2. Glass

        13.7.3. Metal 

        13.7.4. Paper

        13.7.5. Corrugated Fiber

    13.8. Historical Market Value(US$ Mn) and Volume (Units), 2017-2020, By End Use

    13.9. Market Size (US$ Mn) and Volume (Units) Forecast Analysis 2021-2028, By End Use

        13.9.1. Research Laboratories

        13.9.2. Clinical Research Organization

        13.9.3. Drug Manufacturing Facilities

    13.10. Market Attractiveness Analysis

        13.10.1. By Country

        13.10.2. By Packaging Type

        13.10.3. By Material

        13.10.4. By End Use

    13.11. Prominent Trends

    13.12. Drivers and Restraints: Impact Analysis

14. Asia Pacific Clinical Trial Packaging Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Market share and Basis Points (BPS) Analysis, By Country

        14.1.2. Y-o-Y Growth Projections, By Country

    14.2. Historical Market Value(US$ Mn) and Volume (Units), 2017-2020, By Country

    14.3. Market Size (US$ Mn) and Volume (Units) Forecast Analysis 2021-2028 By Country

        14.3.1. China

        14.3.2. India

        14.3.3. Japan

        14.3.4. ASEAN

        14.3.5. Australia and New Zealand

        14.3.6. Rest of APAC

    14.4. Historical Market Value(US$ Mn) and Volume (Units), 2017-2020, By Packaging Type

    14.5. Market Size (US$ Mn) and Volume (Units) Forecast Analysis 2021-2028, By Packaging Type

        14.5.1. Syringes

        14.5.2. Vials & Ampoules

        14.5.3. Blisters

            14.5.3.1. Cold Forming

            14.5.3.2. Thermoforming

        14.5.4. Tubes

        14.5.5. Bottles

        14.5.6. Bags & Pouches

        14.5.7. Sachets

        14.5.8. Kits or Packs

        14.5.9. Others

    14.6. Historical Market Value(US$ Mn) and Volume (Units), 2017-2020, By Material

    14.7. Market Size (US$ Mn) and Volume (Units) Forecast Analysis 2021-2028, By Material

        14.7.1. Plastic

            14.7.1.1. PVC

            14.7.1.2. PE

                14.7.1.2.1. HDPE

                14.7.1.2.2. LDPE

            14.7.1.3. PP

            14.7.1.4. Others

        14.7.2. Glass

        14.7.3. Metal 

        14.7.4. Paper

        14.7.5. Corrugated Fiber

    14.8. Historical Market Value(US$ Mn) and Volume (Units), 2017-2020, By End Use

    14.9. Market Size (US$ Mn) and Volume (Units) Forecast Analysis 2021-2028, By End Use

        14.9.1. Research Laboratories

        14.9.2. Clinical Research Organization

        14.9.3. Drug Manufacturing Facilities

    14.10. Market Attractiveness Analysis

        14.10.1. By Country

        14.10.2. By Packaging Type

        14.10.3. By Material

        14.10.4. By End Use

    14.11. Prominent Trends

    14.12. Drivers and Restraints: Impact Analysis

15. Middle East and Africa Clinical Trial Packaging Market Analysis and Forecast

    15.1. Introduction

        15.1.1. Market share and Basis Points (BPS) Analysis, By Country

        15.1.2. Y-o-Y Growth Projections, By Country

    15.2. Historical Market Value(US$ Mn) and Volume (Units), 2017-2020, By Country

    15.3. Market Size (US$ Mn) and Volume (Units) Forecast Analysis 2021-2028, By Country

        15.3.1. North Africa

        15.3.2. GCC countries

        15.3.3. South Africa

        15.3.4. Turkey

        15.3.5. Rest of MEA

    15.4. Historical Market Value(US$ Mn) and Volume (Units), 2017-2020, By Packaging Type

    15.5. Market Size (US$ Mn) and Volume (Units) Forecast Analysis 2021-2028, By Packaging Type

        15.5.1. Syringes

        15.5.2. Vials & Ampoules

        15.5.3. Blisters

            15.5.3.1. Cold Forming

            15.5.3.2. Thermoforming

        15.5.4. Tubes

        15.5.5. Bottles

        15.5.6. Bags & Pouches

        15.5.7. Sachets

        15.5.8. Kits or Packs

        15.5.9. Others

    15.6. Historical Market Value(US$ Mn) and Volume (Units), 2017-2020, By Material

    15.7. Market Size (US$ Mn) and Volume (Units) Forecast Analysis 2021-2028, By Material

        15.7.1. Plastic

            15.7.1.1. PVC

            15.7.1.2. PE

                15.7.1.2.1. HDPE

                15.7.1.2.2. LDPE

            15.7.1.3. PP

            15.7.1.4. Others

        15.7.2. Glass

        15.7.3. Metal 

        15.7.4. Paper

        15.7.5. Corrugated Fiber

    15.8. Historical Market Value(US$ Mn) and Volume (Units), 2017-2020, By End Use

    15.9. Market Size (US$ Mn) and Volume (Units) Forecast Analysis 2021-2028, By End Use

        15.9.1. Research Laboratories

        15.9.2. Clinical Research Organization

        15.9.3. Drug Manufacturing Facilities

    15.10. Market Attractiveness Analysis

        15.10.1. By Country

        15.10.2. By Packaging Type

        15.10.3. By Material

        15.10.4. By End Use

    15.11. Prominent Trends

    15.12. Drivers and Restraints: Impact Analysis

16. Competitive Landscape

    16.1. Market Structure

    16.2. Competition Dashboard

    16.3. Company Market Share Analysis

    16.4. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments, SWOT analysis)

    16.5. Competition Deep Dive

          (Global Players)

        16.5.1. lcare Ltd.

                16.5.1.1. Overview 

                16.5.1.2. Financials

                16.5.1.3. Strategy

                16.5.1.4. Recent Developments

                16.5.1.5. SWOT Analysis

        16.5.2. Fisher Clinical Services, Inc

                16.5.2.1. Overview 

                16.5.2.2. Financials

                16.5.2.3. Strategy

                16.5.2.4. Recent Developments

                16.5.2.5. SWOT Analysis

        16.5.3.  WuXi AppTec, Inc

                16.5.3.1. Overview 

                16.5.3.2. Financials

                16.5.3.3. Strategy

                16.5.3.4. Recent Developments

                16.5.3.5. SWOT Analysis

        16.5.4.  PCI Pharma Services

                16.5.4.1. Overview 

                16.5.4.2. Financials

                16.5.4.3. Strategy

                16.5.4.4. Recent Developments

                16.5.4.5. SWOT Analysis

        16.5.5.  Almac Group Limited

                16.5.5.1. Overview 

                16.5.5.2. Financials

                16.5.5.3. Strategy

                16.5.5.4. Recent Developments

                16.5.5.5. SWOT Analysis

        16.5.6.  PharMaterials Ltd

                16.5.6.1. Overview 

                16.5.6.2. Financials

                16.5.6.3. Strategy

                16.5.6.4. Recent Developments

                16.5.6.5. SWOT Analysis

        16.5.7.  PAREXEL International Corp

                16.5.7.1. Overview 

                16.5.7.2. Financials

                16.5.7.3. Strategy

                16.5.7.4. Recent Developments

                16.5.7.5. SWOT Analysis

        16.5.8.  Schreiner MediPharm

                16.5.8.1. Overview 

                16.5.8.2. Financials

                16.5.8.3. Strategy

                16.5.8.4. Recent Developments

                16.5.8.5. SWOT Analysis

        16.5.9.  Sharp Packaging Systems, LLC

                16.5.9.1. Overview 

                16.5.9.2. Financials

                16.5.9.3. Strategy

                16.5.9.4. Recent Developments

                16.5.9.5. SWOT Analysis

        16.5.10.  The Coghlan Group Inc

                16.5.10.1. Overview 

                16.5.10.2. Financials

                16.5.10.3. Strategy

                16.5.10.4. Recent Developments

                16.5.10.5. SWOT Analysis

        16.5.11.  Rubicon Research Private Limited

                16.5.11.1. Overview 

                16.5.11.2. Financials

                16.5.11.3. Strategy

                16.5.11.4. Recent Developments

                16.5.11.5. SWOT Analysis

        16.5.12.  Westrock Company

                16.5.12.1. Overview 

                16.5.12.2. Financials

                16.5.12.3. Strategy

                16.5.12.4. Recent Developments

                16.5.12.5. SWOT Analysis

        16.5.13.  Xerimis Inc

                16.5.13.1. Overview 

                16.5.13.2. Financials

                16.5.13.3. Strategy

                16.5.13.4. Recent Developments

                16.5.13.5. SWOT Analysis

        16.5.14.  Catalent, Inc

                16.5.14.1. Overview 

                16.5.14.2. Financials

                16.5.14.3. Strategy

                16.5.14.4. Recent Developments

                16.5.14.5. SWOT Analysis

        16.5.15.  Piramal Enterprises Ltd

                16.5.15.1. Overview 

                16.5.15.2. Financials

                16.5.15.3. Strategy

                16.5.15.4. Recent Developments

                16.5.15.5. SWOT Analysis

        16.5.16.  Corden Pharma GmbH

                16.5.16.1. Overview 

                16.5.16.2. Financials

                16.5.16.3. Strategy

                16.5.16.4. Recent Developments

                16.5.16.5. SWOT Analysis

        16.5.17. NextPharma Technologies

                16.5.17.1. Overview 

                16.5.17.2. Financials

                16.5.17.3. Strategy

                16.5.17.4. Recent Developments

                16.5.17.5. SWOT Analysis

        16.5.18. Sentry BioPharma Services

                16.5.18.1. Overview 

                16.5.18.2. Financials

                16.5.18.3. Strategy

                16.5.18.4. Recent Developments

                16.5.18.5. SWOT Analysis

        16.5.19. Körber Medipak Systems AG

                16.5.19.1. Overview 

                16.5.19.2. Financials

                16.5.19.3. Strategy

                16.5.19.4. Recent Developments

                16.5.19.5. SWOT Analysis

        16.5.20. DMB Consultancy

                16.5.20.1. Overview 

                16.5.20.2. Financials

                16.5.20.3. Strategy

                16.5.20.4. Recent Developments

                16.5.20.5. SWOT Analysis

        *The list of companies is indicative in nature and is subject to change during the course of research

17. Assumptions and Acronyms Used

18. Research Methodology

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers